Clinical Trial Update: Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating whether functional imaging can predict response to abemaciclib in advanced hormone receptor-positive, HER2-negative breast cancer; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hormone Receptor-positive Breast Cancer

Drugs mentioned

• VERZENIO (ABEMACICLIB)

Snippet

Sponsor: University of Washington | Conditions: Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 | Phase 2 | Status: RECRUITING